BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 33073587)

  • 1. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
    Zhang X; Agborbesong E; Li X
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological Role of Organelle Stress/Crosstalk in AKI-to-CKD Transition.
    Maekawa H; Inagi R
    Semin Nephrol; 2019 Nov; 39(6):581-588. PubMed ID: 31836040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
    Small DM; Sanchez WY; Roy SF; Morais C; Brooks HL; Coombes JS; Johnson DW; Gobe GC
    Am J Physiol Renal Physiol; 2018 May; 314(5):F956-F968. PubMed ID: 29357409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia as a key player in the AKI-to-CKD transition.
    Tanaka S; Tanaka T; Nangaku M
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1187-95. PubMed ID: 25350978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.
    Franzin R; Stasi A; Fiorentino M; Stallone G; Cantaluppi V; Gesualdo L; Castellano G
    Front Immunol; 2020; 11():734. PubMed ID: 32457738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic impairment of mitochondrial bioenergetics and β-oxidation promotes experimental AKI-to-CKD transition induced by folic acid.
    Aparicio-Trejo OE; Avila-Rojas SH; Tapia E; Rojas-Morales P; León-Contreras JC; Martínez-Klimova E; Hernández-Pando R; Sánchez-Lozada LG; Pedraza-Chaverri J
    Free Radic Biol Med; 2020 Jul; 154():18-32. PubMed ID: 32360615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.
    He L; Wei Q; Liu J; Yi M; Liu Y; Liu H; Sun L; Peng Y; Liu F; Venkatachalam MA; Dong Z
    Kidney Int; 2017 Nov; 92(5):1071-1083. PubMed ID: 28890325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response.
    Strausser SA; Nakano D; Souma T
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):314-322. PubMed ID: 29702491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitophagy in Acute Kidney Injury and Kidney Repair.
    Wang Y; Cai J; Tang C; Dong Z
    Cells; 2020 Feb; 9(2):. PubMed ID: 32024113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.
    Chou YH; Chu TS; Lin SL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():121-125. PubMed ID: 30298669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases.
    Aranda-Rivera AK; Cruz-Gregorio A; Aparicio-Trejo OE; Pedraza-Chaverri J
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
    Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling.
    Li ZL; Wang B; Lv LL; Tang TT; Wen Y; Cao JY; Zhu XX; Feng ST; Crowley SD; Liu BC
    Acta Pharmacol Sin; 2021 Dec; 42(12):2106-2119. PubMed ID: 33658705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Signaling, the Mechanisms of AKI-to-CKD Transition and Potential Treatment Targets.
    Chang LY; Chao YL; Chiu CC; Chen PL; Lin HY
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel insights into acute kidney injury-chronic kidney disease continuum and the role of renin-angiotensin system.
    Chou YH; Huang TM; Chu TS
    J Formos Med Assoc; 2017 Sep; 116(9):652-659. PubMed ID: 28615146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
    Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
    Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
    Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
    Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.